Assignee
DEPOMED INC
US·32 granted patents·24 pending applications·3,135 citations·filing 1995–2017
Top patents by PatentIndex Score
56 records- 0199US6488962B1Tablet shapes to enhance gastric retention of swellable controlled-release oral dosage formsDEPOMED INC·Filed 2000·Granted Dec 3, 2002·442 cites·27 claims
- 0298US7731989B2Gastric retained gabapentin dosage formDEPOMED INC·Filed 2008·Granted Jun 8, 2010·22 cites·20 claims
- 0398US6635280B2Extending the duration of drug release within the stomach during the fed modeDEPOMED INC·Filed 2001·Granted Oct 21, 2003·282 cites·70 claims
- 0498US6340475B2Extending the duration of drug release within the stomach during the fed modeDEPOMED INC·Filed 1999·Granted Jan 22, 2002·519 cites·89 claims
- 0598US5972389AGastric-retentive, oral drug dosage forms for the controlled-release of sparingly soluble drugs and insoluble matterDEPOMED INC·Filed 1996·Granted Oct 26, 1999·456 cites·33 claims
- 0698US5582837AAlkyl-substituted cellulose-based sustained-release oral drug dosage formsDEPOMED INC·Filed 1995·Granted Dec 10, 1996·314 cites·34 claims
- 0797US6682759B2Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugsDEPOMED INC·Filed 2002·Granted Jan 27, 2004·203 cites·14 claims
- 0896US7976870B2Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tractDEPOMED INC·Filed 2004·Granted Jul 12, 2011·82 cites·23 claims
- 0996US7438927B2Methods of treatment using a gastric retained gabapentin dosageDEPOMED INC·Filed 2003·Granted Oct 21, 2008·56 cites·67 claims
- 1095US9566258B2Gastric retentive pharmaceutical compositions for treatment and prevention of CNS disordersDEPOMED INC·Filed 2015·Granted Feb 14, 2017·17 cites·15 claims
- 1195US8945619B2Shell-and-core dosage form approaching zero-order drug releaseDEPOMED INC·Filed 2012·Granted Feb 3, 2015·28 cites·23 claims
- 1295US8372432B2Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesicDEPOMED INC·Filed 2009·Granted Feb 12, 2013·20 cites·27 claims
- 1395US8043630B2Shell-and-core dosage form approaching zero-order drug releaseDEPOMED INC·Filed 2010·Granted Oct 25, 2011·26 cites·20 claims
- 1494US8999388B2Dual drug dosage forms with improved separation of drugsDEPOMED INC·Filed 2014·Granted Apr 7, 2015·11 cites·17 claims
- 1594US8377453B2Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesicDEPOMED INC·Filed 2009·Granted Feb 19, 2013·47 cites·29 claims
- 1694US6723340B2Optimal polymer mixtures for gastric retentive tabletsDEPOMED INC·Filed 2001·Granted Apr 20, 2004·299 cites·19 claims
- 1793US9572780B2Dual drug dosage forms with improved separation of drugsDEPOMED INC·Filed 2015·Granted Feb 21, 2017·12 cites·18 claims
- 1892US9937142B2Gastric retentive pharmaceutical compositions for treatment and prevention of CNS disordersDEPOMED INC·Filed 2017·Granted Apr 10, 2018·9 cites·15 claims
- 1991US7405238B2Pharmacological inducement of the fed mode for enhanced drug administration to the stomachDEPOMED INC·Filed 2002·Granted Jul 29, 2008·36 cites·5 claims
- 2090US9597338B2Shell-and-core dosage form approaching zero-order drug releaseDEPOMED INC·Filed 2014·Granted Mar 21, 2017·9 cites·24 claims
- 2190US9301934B2Gastric retentive dosage forms for extended release of acamprosate into the upper gastrointestinal tractDEPOMED INC·Filed 2015·Granted Apr 5, 2016·9 cites·6 claims
- 2290US7736667B2Shell-and-core dosage form approaching zero-order drug releaseDEPOMED INC·Filed 2002·Granted Jun 15, 2010·26 cites·55 claims
- 2389US8802157B2Methods of treatment using a gastric retained gabapentin dosage formDEPOMED INC·Filed 2013·Granted Aug 12, 2014·7 cites·13 claims
- 2489US8592481B2Gastric retentive gabapentin dosage forms and methods for using sameDEPOMED INC·Filed 2012·Granted Nov 26, 2013·8 cites·12 claims
- 2589US7612112B2Methods of treatment using a gastric retained gabapentin dosageDEPOMED INC·Filed 2004·Granted Nov 3, 2009·20 cites·18 claims
- 2687US7413751B2Methods of treatment using a gastric retained losartan dosageDEPOMED INC·Filed 2002·Granted Aug 19, 2008·31 cites·20 claims
- 2787US6451808B1Inhibition of emetic effect of metformin with 5-HT3 receptor antagonistsDEPOMED INC·Filed 2000·Granted Sep 17, 2002·142 cites·11 claims
- 2876US8252332B2Gastric retained gabapentin dosage formDEPOMED INC·Filed 2010·Granted Aug 28, 2012·1 cites·24 claims
- 2974US2015157558A1Methods of treatment using a gastric retained gabapentin dosage formDEPOMED INC·Filed 2014·Application pending·0 cites
- 3072US9801816B2Gastric retentive dosage forms for extended release of acamprosate into the upper gastrointestinal tractDEPOMED INC·Filed 2016·Granted Oct 31, 2017·1 cites·15 claims
- 3172US8580303B2Gastric retained gabapentin dosage formDEPOMED INC·Filed 2013·Granted Nov 12, 2013·0 cites·16 claims
- 3271US9561200B2Method of treating post-surgical acute painDEPOMED INC·Filed 2013·Granted Feb 7, 2017·0 cites·16 claims
- 3370US2009176882A1Gastric retentive gabapentin dosage forms and methods for using sameDEPOMED INC·Filed 2008·Application pending·0 cites
- 3470US2014186440A1Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesicDEPOMED INC·Filed 2014·Application pending·0 cites
- 3567US2016263044A1Methods of treatment using a gastric retained gabapentin dosage formDEPOMED INC·Filed 2016·Application pending·0 cites
- 3667US2017128400A1Method of treating post-surgical acute painDEPOMED INC·Filed 2017·Application pending·0 cites
- 3766US2014072623A1Gastric retained gabapentin dosage formDEPOMED INC·Filed 2013·Application pending·0 cites
- 3866US2009028941A1Pulsatile gastric retentive dosage formsDEPOMED INC·Filed 2008·Application pending·0 cites
- 3966US2017202817A1Dual drug dosage forms with improved separation of drugsDEPOMED INC·Filed 2017·Application pending·0 cites
- 4063US2014135395A1Gastric retentive gabapentin dosage forms and methods for using sameDEPOMED INC·Filed 2013·Application pending·0 cites
- 4163US2016206558A1Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesicDEPOMED INC·Filed 2016·Application pending·0 cites
- 4262US2006159743A1Methods of treating non-nociceptive pain states with gastric retentive gabapentinDEPOMED INC·Filed 2005·Application pending·0 cites
- 4361US2017172930A1Shell-and-core dosage form approaching zero-order drug releaseDEPOMED INC·Filed 2017·Application pending·0 cites
- 4456US9814705B2Intranasal spray device containing pharmaceutical compositionDEPOMED INC·Filed 2015·Granted Nov 14, 2017·0 cites·26 claims
- 4555US2013149379A1Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tractDEPOMED INC·Filed 2012·Application pending·0 cites
- 4655US2011218246A1Methods of treating non-nociceptive pain states with gastric retentive gabapentinDEPOMED INC·Filed 2011·Application pending·0 cites
- 4753US2002051820A1Extending the duration of drug release within the stomach during the fed modeDEPOMED INC·Filed 2001·Application pending·0 cites
- 4853US2007184104A1Gastric retentive gabapentin dosage forms and methods for using sameDEPOMED INC·Filed 2006·Application pending·0 cites
- 4953US2013158121A1Methods for treating vasomotor symptoms using gaba analogs in a gastric retentive dosage formDEPOMED INC·Filed 2012·Application pending·0 cites
- 5052US2013316002A1Compositions and methods for treating gastrointestinal motility dysfunctionDEPOMED INC·Filed 2013·Application pending·0 cites
Showing the top 50 of 56 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →